Licensing, translation and linguistic validation, and eCOA migration can require coordinating multiple vendors. TransPerfect’s COA solutions bring your entire program under one accountable team that works with the platforms you already use. From paper through the final electronic build, we help keep your instrument accurate.
Get in Touch
When different vendors manage licensing, translation, and eCOA migration, communication is decentralized. Missed handoffs can impact quality and extend timelines, leaving study teams to fill workflow gaps:
Multiple vendor handoffs add review cycles that can delay submission to an ethics committee or IRB, as well as the study’s first dosing visit.
Licensing requirements don't automatically follow the instrument to the next vendor, risking copyright compliance.
An unvalidated or unchecked translation risks data validity once it’s built into the electronic platform.
TransPerfect manages your clinical outcome assessment (COA) translations, electronic COA migration, and full COA program with end-to-end or individual services. One team secures licensing, translates the instrument, and checks the electronic build against the translation before it goes live. Our specialists advise across the full program lifecycle, from technology and COA strategy to licensing, localization, digital health, and AI with human-in-the-loop.
TransPerfect is certified to ISO 9001, ISO 17100, ISO 13485, and applicable EN standards. Every translation follows FDA, EMA, PMDA, and MHRA guidance, as well as ISPOR guidelines for linguistic validation. Our services are fully documented and traceable to your original instrument.
Adherance to regulatory requirements
Validate Systems
IP
Network 2
Whether your study is still a few years away or you’re already enrolling patients, the right time to act is now. We can help you secure licensing, initiate linguistic validation, and meet key milestones to keep your COA and eCOA programs on track.
How are COAs and eCOAs translated for global trials?
We provide COA translation and linguistic validation based on the source instrument. The process begins with concept definition and proceeds through dual forward translation, reconciliation, back translation, and resolution. Patient-facing instruments are validated through cognitive debriefing with members of the target patient population, while other types of COAs undergo clinician review. A final report documents every decision.
For eCOA, we handle electronic clinical outcome assessment adaptation electronic clinical outcome assessment implementation. We migrate the validated translation to the electronic platform and check it against the source using GlobalLink XCompare and GlobalLink Strings before deployment.
What is cognitive debriefing?
Cognitive debriefing is a step in the linguistic validation process in which members of the target patient population review the translated instrument and explain their understanding of it in their own words. This qualitative interview confirms that the translation captures the clinical concept being measured, rather than simply providing a literal, dictionary-accurate translation.
A translation can be technically accurate yet alter the meaning enough to affect how a patient responds. Cognitive debriefing is designed to identify these issues before the instrument is used in a study while also ensuring that it is culturally appropriate for the target audience.
What is linguistic validation and how does it affect regulatory review?
Linguistic validation is a documented process that confirms that a translated COA measures the same clinical concept as the source instrument and is culturally appropriate for the target audience. Regulators, including the FDA and EMA, expect this validation because unvalidated translations can produce inconsistent data across countries and potentially jeopardize a submission.
What is conceptual equivalence?
Conceptual equivalence is the goal of linguistic validation and cognitive debriefing: translating an instrument so that it captures the same clinical meaning as the original. Linguistic validation is the overall process, and cognitive debriefing is one of the steps used to confirm conceptual equivalence. Without it, patients in different countries may effectively be answering different questions, compromising pooled trial data.
How are translations managed across scales and global studies?
TransPerfect maintains centralized glossaries and translation memories for each study. This approach keeps terminology consistent across every scale within an instrument and across all languages and sites, from the initial protocol through the final submission.
How long does the full COA-to-eCOA process take, from translation through migration?
Timelines depend on the instrument, language count, and study scope, but translation and linguistic validation typically take 8–12 weeks. For copyrighted instruments, additional time is needed upfront to license the instrument and obtain the materials required for translation and eCOA implementation. Migration and screenshot review require additional time after the translation has been validated.
How do I license a copyrighted COA or instrument?
TransPerfect works directly with instrument developers and authors to ensure that the necessary licensing permissions are in place before translation begins. If the instrument will also be deployed electronically, a separate license is often required for the digital version, sometimes from a different rights holder than the paper version. We can help you secure both.
Case studies and expert insights on how sponsors run their COA and eCOA programs.
